Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Industry, Sector and Symbol:
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NYSE:ZMH
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $113.34
- 200 Day Moving Avg: $115.50
- 52 Week Range: $94.73 - $121.84
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 16.41
- P/E Growth: 0.00
- Average Volume: 1.13 million shs.
Frequently Asked Questions for Zimmer Biomet Holdings (NYSE:ZMH)
What is Zimmer Biomet Holdings' stock symbol?
Zimmer Biomet Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZMH."
Who are some of Zimmer Biomet Holdings' key competitors?
Some companies that are related to Zimmer Biomet Holdings include HDFC Bank Limited (HDB), Berkshire Hathaway (BRK.B), Berkshire Hathaway (BRK.A), Exxon Mobil (XOM), Johnson & Johnson (JNJ), Alibaba Group Holding Ltd (BABA), JPMorgan Chase & Co. (JPM), Wells Fargo & Co (WFC), Bank of America Corp (BAC), General Electric Company (GE), Wal-Mart Stores (WMT), Royal Dutch Shell plc (RDS.B), AT&T (T), Anheuser Busch Inbev NV (BUD), China Mobile (CHL), Procter & Gamble Co (PG), Royal Dutch Shell plc (RDS.A) and Visa (V).
Who are Zimmer Biomet Holdings' key executives?
Zimmer Biomet Holdings' management team includes the folowing people:
- David C. Dvorak, President, Chief Executive Officer, Director
- Daniel P. Florin, Chief Financial Officer, Senior Vice President
- Robert D. Delps, President, Americas
- Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa
- Sang Yi, President, Asia Pacific
- Chad F. Phipps, Senior Vice President, General Counsel, Secretary
- Larry C. Glasscock, Independent Non-Executive Chairman of the Board
- Christopher B. Begley, Independent Director
- Betsy J. Bernard, Independent Director
- Gail Koziara Boudreaux, Independent Director
How do I buy Zimmer Biomet Holdings stock?
Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Zimmer Biomet Holdings' stock price today?
MarketBeat Community Rating for Zimmer Biomet Holdings (NYSE ZMH)MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $113.56.
Earnings History for Zimmer Biomet Holdings (NYSE:ZMH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZMH)
Current Year EPS Consensus Estimate: $6.36 EPS
Next Year EPS Consensus Estimate: $6.92 EPS
Dividend History for Zimmer Biomet Holdings (NYSE:ZMH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Zimmer Biomet Holdings (NYSE:ZMH)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Zimmer Biomet Holdings (NYSE:ZMH)
Latest Headlines for Zimmer Biomet Holdings (NYSE:ZMH)
Zimmer Biomet Holdings (ZMH) Chart for Tuesday, May, 30, 2017